The Pharmaceutical Industry is faced with the challenge of implementing and managing innovation in an era of rapid technological advancement.

Pharmaceuticals is the sector where innovation has a dramatic impact on the health and wellness of millions of people and the bottom lines of companies that drive it forward.

Companies have come to realize that in order to increase R&D productivity, they need to dramatically improve their ability to harness knowledge and capabilities residing both within and beyond their organizational boundaries—through strategic alliances, partnerships, and AI-driven collaborations.

For most pharmaceutical companies, innovation is the central element of their corporate mission, now amplified by AI's transformative role from discovery to development.

With AI projected to drive 30% of new drug discoveries by 2025, cutting costs and accelerating personalized treatments, the industry recognizes the vital need for implementing advanced digital technologies, such as Big Data Analytics, Artificial Intelligence, and other digital tools, to thrive and stay closer to patient needs—a trend that has only accelerated into the AI-native era of 2026.

Join our Global Innovation in Pharmaceutical R&D Summit 2026: Strategic AI in Pharma R&D: From Discovery to Development Partnerships, and gain the latest innovative insights from leading pharmaceutical, biotechnology, and AI companies.

WHO SHOULD ATTEND

IF YOU WORK IN PHARMACEUTICAL, BIOTECHNOLOGY, CRO, CMO, CDMO COMPANIES IN ANY CAPACITY:

STRATEGIC & PARTNERING
ALLIANCE SOURCING & MANAGEMENT
CORPORATE RESEARCH & NETWORKING
DRUG DISCOVERY
TECHNOLOGY SCOUTING & NEW TECHNOLOGY
SCIENTIFIC AFFAIRS
LEGAL DIGITAL/AI IN PHARM
MARKETING

OPEN INNOVATION
EXTERNAL COLLABORATION & INNOVATION
EXTERNAL NETWORKS & PARTNERSHIPS
CORPORATE BUSINESS DEVELOPMENT
R&D
EXTERNAL DRUG DISCOVERY
BUSINESS DEVELOPMENT
STRATEGIC ALLIANCE MANAGEMENT

WHY YOU SHOULD ATTEND

Meet the world’s market-leading Pharmaceutical, Biotech, and AI companies at the forefront of R&D innovation
Discover practical AI-driven solutions for challenges in drug discovery, development, and partnerships
Engage in a collaborative platform to share know-how among Big Pharma R&D leaders
Learn from best-practice examples, case studies, and lessons on integrating AI into preclinical and translational pipelines
Expand your professional network, explore potential alliances, and discuss co-development opportunities with industry peers
Gain a competitive advantage in the AI-native pharma landscape and rapidly evolving regulatory environment
Influence and help shape the future of AI-powered R&D trends and strategic partnerships through 2030

CONFERENCE TOPICS

DAY ONE

Pharma 2030: Strategic alliances as the key driver of innovation
From molecules to markets - how technology is redefining R&D strategy
Rethinking Pharmaceutical R&D: How AI is transforming decision-making from discovery to development
From target to therapy: Novel approach opportunities for pharma R&D
From AI startup to preclinical partner: How to select, structure, and scale external innovation in pharma R&D
When pigs fly, or rather, when pandas fall
Alliance risk management - licensing AI models, IP ownership, Data sharing agreements
What must be in AI-R&D contracts to withstand regulatory audits in 2030
CMC and process development beyond technology transfer
The 5-year horizon for AI partnerships in R&D